题干

2014年11月20日,国务院发布《关于扶持小型微型企业健康发展的意见》,从资金支持、财税优惠、创业基地建设、促进企业信息互联互通等方面提出一系列政策措施,扶持小型微型企业(含个体工商户)健康发展。这 (  )

①符合社会主义初级阶段的基本国情

②说明非公有制经济在我国的经济大舞台上唱主角

③有助于调动社会各方面的积极性

④有助于促进国民经济又好又快发展

A:①③④

B:①②③

C:②③④

D:①②④

上一题 下一题 0.0难度 选择题 更新时间:2012-01-12 11:52:00

答案(点此获取答案解析)

A

同类题2

阅读理解

    Health experts are calling for action to increase cancer care and control in the developing world. A medical research paper says cancer was once thought of as a problem mostly in the developed world. But now cancer is a leading cause of death and disability in poor countries as well. Experts from Harvard University and other organizations urge the international community to fight cancer actively, saying it should be fought in the way HIV/AIDS has been fought in Africa.

    Cancer kills more than 7.5 million people a year worldwide. Almost two thirds are in low-income and middle-income countries.

    They discover cancer kills more people in developing countries than AIDS, tuberculosis and malaria combined. But the world spends only 5﹪ of its cancer resources in those countries.

    Felicia Knaul from Harvard Medical School was one of the writers of the paper. She was in Mexico when she was found to have breast cancer. She received treatment there and her experience showed her the sharp difference between the rich and the poor in treating breast cancer.

    Felicia Knaul says, “And we are seeing how this is attacking young women. It's the number two cause of death in Mexico of women thirty to fifty-four. All over the developing world, it's the number one cancer-related death among young women. I think we have to again say that there is much more we could do about it than we are doing about it. ”

    Professor Knaul met community health workers during her work in developing countries. They were an important part of efforts to reduce deaths from the cancer. They were able to persuade people to get tested to prevent the illness. The experts say cancer care does not have to be costly. For example, patients can be treated with lower-cost drugs.